Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer.
Atul BatraLin YangDevon J BoyneAndrew HarperWinson Y CheungColleen Ann CuthbertPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
A single assessment of baseline symptom burden using the ESASr in patients with metastatic cancer has significant prognostic value. This may represent a feasible first step towards routine collection of patient-reported outcomes in real-world settings where serial symptom measurements can be challenging to implement.